GlassScriptPhysician profile
Henry Holland
NPI 1982671582
$2,980.04
in general payments reported to CMS, 2019-2025
22 companies · $517 in 2025
The $517 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,851 · 2020: $61.79 · 2021: $62.86 · 2022: $62.09 · 2023: $250 · 2024: $176 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902 · Education: $39.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.43 |
| Education | $39.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,485.00 | 2019 | |
| Celgene Corporation | $566.61 | 2019-2025 | Breyanzi, Reblozyl, Onureg |
| Astellas Pharma US INC | $167.72 | 2019-2020 | |
| Iovance Biotherapeutics, INC. | $154.44 | 2025 | Amtagvi |
| Abbvie INC. | $81.75 | 2019-2025 | |
| Incyte Corporation | $70.12 | 2019-2023 | Jakafi |
| Kite Pharma, INC. | $69.75 | 2024-2025 | Yescarta |
| Epizyme, INC. | $53.87 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.12 | 2021-2024 | Iclusig |
| Amgen INC. | $52.11 | 2019 | |
| Seagen INC. | $34.37 | 2019 | |
| Morphosys, US INC. | $34.25 | 2022-2023 | Monjuvi |
| Jazz Pharmaceuticals INC. | $30.80 | 2019-2023 | Zepzelca |
| Novartis Pharmaceuticals Corporation | $22.74 | 2019 | |
| Karyopharm Therapeutics INC. | $21.78 | 2025 | Xpovio |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.59 | 2024 | Jaypirca |
| Glaxosmithkline, LLC. | $18.25 | 2024 | Ojjaara |
| Adaptive Biotechnologies Corporation | $16.10 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $14.21 | 2019 | |
| Servier Pharmaceuticals LLC | $12.46 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Holland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.